$2.71
0.3414.35%
At Close: -
$2.46
-0.25-9.23%
After Hours: 9:27 AM EDT
15 minutes delayed
Moleculin Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Moleculin Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-1.70 | $-2.31 | 26.4 % |
Mar 2024 | 2024-05-10 | $-2.02 | $-3.53 | 42.8 % |
Dec 2023 | 2024-03-22 | $-5.09 | $-3.05 | -66.9 % |
Sep 2023 | 2023-11-13 | $-2.85 | $-3.60 | 20.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Moleculin Biotech (MBRX) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-1.70, which beat the estimate of $-2.31.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.